UiPath (PATH) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

We recently published a list of 10 Best Mid Cap AI Stocks to Buy Now. In this article, we are going to take a look at where ...

While the AI boom is still going strong, there are a few reasons to believe that the industry is vastly overselling the ...

The robotics industry has grown modestly over the past few years. Robotic companies are growing faster than ever, driven by ...

A number of analysts have recently issued reports on the stock. Morgan Stanley cut their target price on shares of UiPath from $16.00 to $12.00 and set an “equal weight” rating for the company ...

UiPath's ARR to reach $1.816B in FY26 amid strong AI automation growth. Explore profitability, valuation, and challenges ...

UiPath (PATH) has seen its stock hit an all-time low following a bleak revenue forecast issued as a part of its Q4 FY 2025 financial results.

We recently published a list of 9 AI News and Ratings on Investors’ Radar. In this article, we are going to take a look at ...

UiPath Inc. PATH stock has declined 50% over the past year against the industry's 22% rally. This analysis will explore PATH's performance to assess whether its current levels offer an attractive ...

Investors should use the technical weakness as a buying opportunity for UiPath stock, as the fundamental setup is currently net positive. Explore more details here.

UiPath (PATH) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.